Page results
-
Information for patients and visitors on patient isolation.
-
This information is for patients, (and their family and carers), who are considering having Uterine Artery (Fibroid) Embolisation (UAE). It explains what is involved and the possible risks.
-
It is important to make sure you are eating and drinking well before your surgery. Good nutrition will also help you recover after your surgery.
-
A high quality diagnostic service for surgical neuropathology, neuromuscular diagnostics, epilepsy, molecular neuropathology of brain tumours, and neurodegenerative diseases.
-
This page has been written for patients who are having a course of superficial radiotherapy for a skin tumour (such as a basal cell carcinoma or squamous cell carcinoma), or some other skin condition.
-
This page is for patients who are having stereotactic ablative body radiotherapy (SABR) for lung cancer.
-
This information has been written to help you now that your radiotherapy treatment is finishing.
-
Postnatal care should be a continuation of the care the woman has received through her pregnancy, labour and birth and take into account the woman’s individual needs and preferences.
-
This page has been written for parents and carers whose child is having radiotherapy treatment to the neck, chest, abdomen, and pelvis.
-
This page is for parents and carers whose child is having radiotherapy treatment to the neck and chest.
File results
-
FOI/2023/0058 - Skin cancer pathway management
-
FOI/2023/0063 - Women who have given birth at the Trust aged 50 or above
-
FOI/2023/0064 - Children's operations cancelled/ delayed for non-clinical reasons from 2018 to 2022
-
FOI/2023/0065 - A&E deaths from 2010 to 2022
-
FOI/2023/0066 - Hospital catering - beef and poultry meat procured
-
FOI/2023/0068 - Intrapartum stillbirths, maternal deaths, neonatal deaths
-
FOI/2023/0069 - Operations waits for under-18s
-
FOI/2023/0073 - Telephony and UC/ collaboration, Microsoft 365 licence and on-premise or cloud storage
-
FOI/2023/0075 - Attrition rates for staff working in advanced practice roles
-
FOI/2023/0080 - Treatment for Myeloid leukaemia (AML) and chronic lymphocytic leukaemia